Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03853525Phase 4Completed
Phase 4, randomised, open-label trial of dexpanthenol (2 arms), sponsored by Bayer. Primary endpoint: Transepidermal water loss up to 23 days. Started Feb 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03853525.